4-Aminoquinoline Inhibitors of the Autophagy-Lysosomal Pathway (ALP) as a Therapeutic Approach For Pancreatic Cancer

Daniel W. Worroll III Pharmacology Chairperson: Dr. Lonny Levin Major Sponsor: Dr. Yueming Li Minor Sponsors: Dr. Lorraine Gudas, Dr. Xuejun Jiang, and Dr. Alban Ordureau